Desq Long
Sign in

Company

Beam Therapeutics Inc.

BEAM · CIK 0001745999

SEC FORM 4
$25,750.00

Beam Therapeutics Inc. (BEAM)

Acquisition (code M) of 25,000 shares at $1.03 per share.

Reporting Person Evans John M. · Officer Title CEO · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →

SEC FORM 4
$599,595.00

Beam Therapeutics Inc. (BEAM)

Sale of 25,000 shares at $23.9838 per share.

Reporting Person Evans John M. · Officer Title CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →

SEC FORM 4
$25,750.00

Beam Therapeutics Inc. (BEAM)

Acquisition (code M) of 25,000 shares at $1.03 per share.

Reporting Person Evans John M. · Officer Title CEO · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →

SEC FORM 4
$589,150.00

Beam Therapeutics Inc. (BEAM)

Sale of 25,000 shares at $23.5660 per share.

Reporting Person Evans John M. · Officer Title CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →

SEC FORM 4
$4,564.67

Beam Therapeutics Inc. (BEAM)

Sale of 187 shares at $24.41 per share.

Reporting Person Cavanagh Bethany J · Officer Title SVP, Finance and Treasurer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412236 · filed 2026-10-02 · View filing →